Ghost Tree Capital as of Sept. 30, 2022
Portfolio Holdings for Ghost Tree Capital
Ghost Tree Capital holds 38 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr Ser Tr S&p Biotech Put Option (XBI) | 11.1 | $40M | 500k | 79.32 | |
| Relmada Therapeutics Put Option (RLMD) | 9.6 | $34M | 925k | 37.02 | |
| Amylyx Pharmaceuticals (AMLX) | 8.3 | $30M | 1.1M | 28.15 | |
| Reata Pharmaceuticals Cl A | 6.5 | $23M | 925k | 25.13 | |
| Axsome Therapeutics Call Option (AXSM) | 5.6 | $20M | 450k | 44.62 | |
| Apellis Pharmaceuticals (APLS) | 5.3 | $19M | 275k | 68.30 | |
| Dice Therapeutics Call Option | 4.0 | $14M | 700k | 20.28 | |
| Mirati Therapeutics | 3.4 | $12M | 175k | 69.84 | |
| Sarepta Therapeutics (SRPT) | 3.4 | $12M | 110k | 110.54 | |
| Cti Biopharma | 3.3 | $12M | 2.0M | 5.82 | |
| Miragen Therapeutics (VRDN) | 3.1 | $11M | 535k | 20.51 | |
| Revance Therapeutics (RVNC) | 3.0 | $11M | 390k | 27.00 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 2.8 | $9.8M | 95k | 103.26 | |
| Iveric Bio Call Option | 2.6 | $9.4M | 525k | 17.94 | |
| Cogent Biosciences (COGT) | 2.5 | $9.0M | 600k | 14.92 | |
| Vaxcyte (PCVX) | 2.4 | $8.6M | 360k | 24.00 | |
| Tricida | 2.1 | $7.3M | 700k | 10.48 | |
| Seagen Call Option | 1.9 | $6.8M | 50k | 136.84 | |
| Karuna Therapeutics Ord | 1.9 | $6.7M | 30k | 224.93 | |
| BioCryst Pharmaceuticals (BCRX) | 1.9 | $6.6M | 525k | 12.60 | |
| Altimmune Com New (ALT) | 1.6 | $5.6M | 435k | 12.77 | |
| Amicus Therapeutics (FOLD) | 1.5 | $5.2M | 500k | 10.44 | |
| Syndax Pharmaceuticals (SNDX) | 1.3 | $4.8M | 200k | 24.03 | |
| Horizon Therapeutics Pub L SHS | 1.3 | $4.6M | 75k | 61.89 | |
| Astria Therapeutics (ATXS) | 1.3 | $4.5M | 500k | 9.04 | |
| Kezar Life Sciences (KZR) | 1.3 | $4.5M | 525k | 8.61 | |
| Blueprint Medicines (BPMC) | 1.2 | $4.3M | 65k | 65.89 | |
| Aadi Bioscience (AADI) | 0.8 | $2.8M | 200k | 14.13 | |
| Intra Cellular Therapies (ITCI) | 0.8 | $2.8M | 60k | 46.53 | |
| Aerovate Therapeutics (AVTE) | 0.7 | $2.5M | 150k | 16.58 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.7 | $2.3M | 300k | 7.76 | |
| Rapt Therapeutics (RAPT) | 0.6 | $2.2M | 90k | 24.06 | |
| Tarsus Pharmaceuticals (TARS) | 0.6 | $2.1M | 120k | 17.12 | |
| Design Therapeutics (DSGN) | 0.5 | $1.7M | 100k | 16.72 | |
| Madrigal Pharmaceuticals (MDGL) | 0.5 | $1.6M | 25k | 65.00 | |
| Rhythm Pharmaceuticals (RYTM) | 0.4 | $1.6M | 65k | 24.51 | |
| Biogen Idec (BIIB) | 0.3 | $1.0M | 3.8k | 266.93 | |
| Aeglea Biotherapeutics | 0.1 | $526k | 1.0M | 0.53 |
